osimertinib drugs market revenue

Osimertinib Drugs Market Growth Outlook Through 2024-2033

August 16, 2024 - by Good PR News

Overview and Scope Osimertinib is a medication used to treat non-small cell lung cancer (NSCLC) in patients with particular abnormal epidermal growth factor (EGFR) genes. It is a kinase inhibitor …

Healthcare

Osimertinib Drugs Global Market 2024 – By Size, Share, Trends, Demand, Forecast To 2033 | Syndax Pharmaceuticals Ltd., Pfizer Inc., F. Hoffmann-La Roche AG

March 28, 2024 - by Good PR News

The Osimertinib Drugs Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, …

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30